Reduced GLUT4 expression and elevated ERK and IGF-1 in CRC patients with MetS correlated with CRC clinical characteristics (e.g., size, distant metastases and more advanced tumor stage) [32]. The gene discussed is SLC2A4; the disease is colorectal carcinoma.